XML 39 R28.htm IDEA: XBRL DOCUMENT v3.21.2
Stock-Based Compensation
6 Months Ended
Jun. 30, 2021
Share-based Payment Arrangement [Abstract]  
Stock-Based Compensation Stock-Based Compensation
 
A. General Information

BMBC permits the issuance of stock options, dividend equivalents, performance stock awards, stock appreciation rights and restricted stock units or awards to employees and directors of the Corporation under several plans. The performance awards and restricted awards may be in the form of stock awards or stock units. Stock awards and stock units differ in that for a stock award, shares of restricted stock are issued in the name of the grantee, whereas a stock unit constitutes a promise to issue shares of stock upon vesting. The accounting for awards and units is identical. The terms and conditions of awards under the plans are determined by the Corporation’s Management Development and Compensation Committee.
 
Prior to April 25, 2007, all shares authorized for grant as stock-based compensation were limited to grants of stock options. On April 25, 2007, the shareholders approved BMBC’s “2007 Long-Term Incentive Plan” (the “2007 LTIP”) under which a total of 428,996 shares of BMBC’s common stock were made available for award grants. On April 28, 2010, the shareholders approved BMBC’s “2010 Long Term Incentive Plan” under which a total of 445,002 shares of BMBC’s common stock were made available for award grants, and on April 30, 2015, the shareholders approved an amendment and restatement of such plan (as amended and restated, the “2010 LTIP”) to, among other things, increase the number of shares available for award grants by 500,000 to 945,002.
 
In addition to the shareholder-approved plans mentioned in the preceding paragraph, BMBC periodically authorizes grants of stock-based compensation as inducement awards to new employees. This type of award does not require shareholder approval in accordance with Rule 5635(c)(4) of the NASDAQ listing rules.
 
The equity awards are authorized to be in the form of, among others, options to purchase BMBC’s common stock, RSUs and PSUs.
 
RSUs have a restriction based on the passage of time. The grant date fair value of the RSUs is based on the closing price on the date of the grant.
 
PSUs have restrictions based on performance criteria and the passage of time. The performance criteria may be a market-based criteria measured by BMBC’s total shareholder return (“TSR”) relative to the performance of the community bank index for the respective period. The fair value of the PSUs based on BMBC’s TSR relative to the performance of a designated peer group or the NASDAQ Community Bank Index is calculated using the Monte Carlo Simulation method. The performance criteria may also be based on a non-market-based criteria such as return on average equity relative to that designated peer group. The grant date fair value of these PSUs is based on the closing price of BMBC’s stock on the date of the grant. PSU grants may have a vesting percent ranging from 0% to 150%.
B. Other Stock Option Information

No options were forfeited, expired, or exercised the three and six months ended June 30, 2021. The following table provides information about options outstanding as of June 30, 2021:
SharesWeighted
Average
Exercise
Price
Weighted
Average
Grant Date
Fair Value
Options outstanding, June 30, 2021225 18.33 12.93 

As of June 30, 2021 there were no unvested options.

Proceeds, related tax benefits realized from options exercised and intrinsic value of options exercised were as follows for the periods presented:
 Three Months Ended
June 30,
Six Months Ended
June 30,
(dollars in thousands)2021202020212020
Proceeds from exercise of stock options$— $— $— $
Related tax benefit recognized— — — 
Net proceeds of options exercised$— $— $— $
Intrinsic value of options exercised$— $— $— $
 
The following table provides information about options outstanding and exercisable at June 30, 2021:
(dollars in thousands, except share data and exercise price)OutstandingExercisable
Number of shares225 225 
Weighted average exercise price$18.33 $18.33 
Aggregate intrinsic value$$
Weighted average remaining contractual term in years2.62.6

C. Restricted Stock Units and Performance Stock Units
 
The Corporation has granted RSUs and PSUs under the 2007 LTIP and 2010 LTIP and in accordance with Rule 5635(c)(4) of the NASDAQ listing standards.

RSUs
 
The compensation expense for the RSUs is measured based on the market price of the stock on the day prior to the grant date and is recognized on a straight-line basis over the vesting period.

For the three and six months ended June 30, 2021, the Corporation recognized $503 thousand and $1.0 million, respectively, of expense related to the Corporation’s RSUs. As of June 30, 2021, there was $2.3 million of unrecognized compensation cost related to RSUs. This cost will be recognized over a weighted average period of 1.7 years.
 
The following table details the RSUs for the three and six months ended June 30, 2021:
 Three Months Ended
June 30, 2021
Six Months Ended
June 30, 2021
 Number of SharesWeighted
Average
Grant Date
Fair Value
Number of SharesWeighted
Average
Grant Date
Fair Value
Beginning balance150,837 $37.25 114,846 $38.00 
Granted— — 36,791 35.09 
Vested— — (800)43.95 
Forfeited(767)38.55 (767)38.55 
Ending balance150,070 37.25 150,070 37.25 

PSUs

For the three months ended June 30, 2021, the Corporation recognized a $51 thousand release of expense related to the PSUs, primarily due to changes in vesting percentages and forfeitures during the three months ended June 30, 2021. For the six months ended June 30, 2021, the Corporation recognized $52 thousand of expense related to the PSUs. As of June 30, 2021, there was $3.0 million of unrecognized compensation cost related to PSUs. This cost will be recognized over a weighted average period of 2.1 years.

The following table details the PSUs for the three and six months ended June 30, 2021:
 Three Months Ended
June 30, 2021
Six Months Ended
June 30, 2021
 Number of SharesWeighted
Average
Grant Date
Fair Value
Number of SharesWeighted
Average
Grant Date
Fair Value
Beginning balance206,055 $36.89 149,911 $37.60 
Granted— — 56,144 34.99 
Vested— — — — 
Forfeited(990)39.70 (990)39.70 
Ending balance205,065 36.88 205,065 36.88